{"id":"CHEMBL101683","canonicalSmiles":"O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1","inchiKey":"GGPZCOONYBPZEW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL101683","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07288"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1160160","canonicalSmiles":"O=C1OC2(c3cc(I)c(O)c(I)c3Oc3c2cc(I)c(O)c3I)c2c(Cl)c(Cl)c(Cl)c(Cl)c21","inchiKey":"IICCLYANAQEHCI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ROSE BENGAL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Rose Bengal Sodium","Rose bengal"],"crossReferences":{"DrugCentral":["4637"],"PubChem":["29218013"],"Wikipedia":["Rose_bengal"],"drugbank":["DB14214"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1171837","canonicalSmiles":"Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12","inchiKey":"PHXJVRSECIGDHY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"PONATINIB","yearOfFirstApproval":2012,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Iclusig"],"synonyms":["AP-24534","AP24534","Ponatinib"],"crossReferences":{"DailyMed":["ponatinib%20hydrochloride"],"PubChem":["137275996"],"Wikipedia":["Ponatinib"],"drugbank":["DB08901"],"chEBI":["78543"]},"childChemblIds":["CHEMBL2105708"],"count":14,"approvedIndications":["EFO_0000616"],"linkedTargets":{"rows":["ENSG00000097007","ENSG00000186716"],"count":2},"linkedDiseases":{"rows":["EFO_0000198","EFO_0000616","EFO_0000220","EFO_0000571","Orphanet_44890","EFO_1000131","EFO_0000222","EFO_0008550","MONDO_0003541","EFO_0003060","EFO_0000311","EFO_0000565","EFO_0000339","EFO_0003841","EFO_0000702","MONDO_0015277","EFO_0000519"],"count":17},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2012 and is indicated for neoplasm and has 13 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1186581","canonicalSmiles":"Cc1ccc(-c2cc([C@@H]3C4CCC(C[C@@H]3c3ccc(Cl)cc3)N4C)on2)cc1","inchiKey":"AUXUFNHAVGIVDC-DXTSEPBQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RTI-336","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["RTI 336","RTI 4229-336","Rti-336"],"childChemblIds":["CHEMBL470690"],"count":3,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL119443","canonicalSmiles":"C[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1","inchiKey":"WVVSZNPYNCNODU-XTQGRXLLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ERGONOVINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Ergometrine"],"crossReferences":{"PubChem":["124882895","144205575","26754288"],"Wikipedia":["Ergometrine"],"drugbank":["DB01253"],"chEBI":["4822"]},"childChemblIds":["CHEMBL1213135"],"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL1200342","canonicalSmiles":"CC(=O)OCC(=O)[C@@]1(O)[C@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C","inchiKey":"HYRKAAMZBDSJFJ-LFDBJOOHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PARAMETHASONE ACETATE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Haldrone"],"synonyms":["Paramethasone","Paramethasone acetate"],"crossReferences":{"PubChem":["144206683"],"drugbank":["DB14657"],"chEBI":["31963"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1200437","canonicalSmiles":"C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@@H](O)c1ccnc2ccc(OC)cc12.O=C(O)[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO","inchiKey":"XHKUDCCTVQUHJQ-LCYSNFERSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"QUINIDINE GLUCONATE","yearOfFirstApproval":1950,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1294","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Duraquin","Quinact","Quinaglute","Quinalan","Quinatime","Quinidine gluconate"],"synonyms":["Quinidine gluconate"],"crossReferences":{"DailyMed":["quinidine%20gluconate"],"chEBI":["27502"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1950. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200479","canonicalSmiles":"CCN(CC)CCOC(=O)C1(C2CCCCC2)CCCCC1.Cl","inchiKey":"GUBNMFJOJGDCEL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DICYCLOMINE HYDROCHLORIDE","yearOfFirstApproval":1950,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1123","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bentyl","Bentyl preservative free","Dicyclomine Hydrochloride (Preservative-Free)","Dicyclomine hydrochloride","Dicyclomine hydrochloride (preservative free)","Merbentyl","Merbentyl 20"],"synonyms":["Dicyclomine hydrochloride","Dicycloverine hydrochloride"],"crossReferences":{"DailyMed":["dicyclomine%20hydrochloride"],"PubChem":["26747501","26747502","50106212","50106213","50106214","56423126","855865"],"chEBI":["4515"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1950."}
{"id":"CHEMBL1200766","canonicalSmiles":"Nc1ccc(S(=O)(=O)Nc2ncccn2)cc1.[Ag]","inchiKey":"FIJFURWTHCVONZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SILVER SULFADIAZINE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL439","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"Wikipedia":["Silver_sulfadiazine"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1200807","canonicalSmiles":"C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=C/C(=N/O)CC[C@@H]4[C@H]3CC[C@@]21CC","inchiKey":"ISHXLNHNDMZNMC-VTKCIJPMSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"NORELGESTROMIN","yearOfFirstApproval":2001,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Evra","Ortho evra"],"synonyms":["Deacetylnorgestimate","Norelgestromin","RWJ-10553"],"crossReferences":{"DailyMed":["norelgestromin"],"PubChem":["144206200"],"Wikipedia":["Norelgestromin"]},"count":3,"linkedTargets":{"rows":["ENSG00000082175"],"count":1},"linkedDiseases":{"rows":["EFO_0000764","HP_0100608","EFO_0002950"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2001 and has 3 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200907","canonicalSmiles":"C[C@]12CC[C@H]3[C@@H](CC[C@@]45O[C@@H]4C(O)=C(C#N)C[C@]35C)[C@@H]1CC[C@@H]2O","inchiKey":"KVJXBPDAXMEYOA-CXANFOAXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRILOSTANE","yearOfFirstApproval":1984,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Modrastane","Modrenal"],"synonyms":["Trilostane","WIN 24,540","WIN-24540"],"crossReferences":{"PubChem":["144206007","144212723","170465836"],"Wikipedia":["Trilostane"],"drugbank":["DB01108"],"chEBI":["32260"]},"count":2,"approvedIndications":["EFO_0005539"],"linkedTargets":{"rows":["ENSG00000203859"],"count":1},"linkedDiseases":{"rows":["EFO_0005539","EFO_0000673"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1984 and is indicated for adrenal gland disease and has 1 investigational indication."}
{"id":"CHEMBL1200971","canonicalSmiles":"CC(=O)OCC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)[C@H](N)c3ccccc3)[C@H]2SC1","inchiKey":"FUBBGQLTSCSAON-PBFPGSCMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEPHALOGLYCIN","yearOfFirstApproval":1970,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Kafocin"],"synonyms":["39435","Cefaloglycin","Cephaloglycin"],"crossReferences":{"Wikipedia":["Cefaloglycin"],"drugbank":["DB00689"],"chEBI":["34613"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1970."}
{"id":"CHEMBL1200980","canonicalSmiles":"C1CNCCN1.C[C@]12CC[C@@H]3c4ccc(OS(=O)(=O)O)cc4CC[C@H]3[C@@H]1CCC2=O","inchiKey":"HZEQBCVBILBTEP-ZFINNJDLSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ESTROPIPATE","yearOfFirstApproval":1977,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL494753","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Estropipate","Harmogen","Ogen","Ogen .625","Ogen 1.25","Ogen 2.5","Ogen 5","Ortho-est"],"synonyms":["Estropipate","Piperazine estrone sulfate"],"crossReferences":{"DailyMed":["estropipate"],"PubChem":["144206901","26750028","56463533"],"Wikipedia":["Estropipate"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1977. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201121","canonicalSmiles":"CC1(C)S[C@@H]2[C@H](N3C(=O)[C@@H](c4ccccc4)NC3(C)C)C(=O)N2[C@H]1C(=O)[O-].[K+]","inchiKey":"QRSPJBLLJXVPDD-XFAPPKAWSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"HETACILLIN POTASSIUM","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201116","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Versapen-k"],"synonyms":["Hetacillin potassium"],"crossReferences":{"chEBI":["34789"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1201124","canonicalSmiles":"NC(CO)(CO)CO.O=C(c1ccccc1)c1ccc2n1CCC2C(=O)O","inchiKey":"BWHLPLXXIDYSNW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"KETOROLAC TROMETHAMINE","yearOfFirstApproval":1989,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL469","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Acular","Acular ls","Acular preservative free","Acuvail","Ketorolac tromethamine","Sprix","Toradol"],"synonyms":["Ketorolac tromethamine"],"crossReferences":{"DailyMed":["ketorolac%20tromethamine"],"PubChem":["124881877","26747544","49681816","50106489","8139924"],"chEBI":["6130"]},"count":12,"approvedIndications":["MP_0001845","EFO_0003843"],"linkedTargets":{"rows":["ENSG00000073756","ENSG00000095303"],"count":2},"linkedDiseases":{"rows":["EFO_0005854","MONDO_0018373","MONDO_0003005","EFO_1001139","EFO_0003777","EFO_0001059","EFO_0005296","EFO_1001178","EFO_0003821","HP_0000545","EFO_0008507","MONDO_0007254","HP_0003418","EFO_0003843","MP_0001845","HP_0030839","EFO_0002506","EFO_0004253","EFO_0005295","HP_0003419","EFO_1000859","HP_0000540","MONDO_0002258","EFO_1001250"],"count":24},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1989 and is indicated for inflammation and pain and has 10 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201183","canonicalSmiles":"CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cc1ccc(S(=O)(=O)O)cc1.Cc1ccc(S(=O)(=O)O)cc1","inchiKey":"UWYXLGUQQFPJRI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1201183","maximumClinicalTrialPhase":0,"parentId":"CHEMBL554","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1201247","canonicalSmiles":"CC(C)C[C@H](NC(=O)[C@@H](COC(C)(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)NNC(N)=O","inchiKey":"BLCLNMBMMGCOAS-URPVMXJPSA-N","drugType":"Protein","blackBoxWarning":false,"name":"GOSERELIN","yearOfFirstApproval":1989,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Zoladex"],"synonyms":["Goserelin","Goserelin acetate","ICI 118,630","ICI-118630"],"crossReferences":{"DailyMed":["goserelin%20acetate"],"Wikipedia":["Goserelin"],"drugbank":["DB00014"]},"childChemblIds":["CHEMBL1200501"],"count":13,"approvedIndications":["EFO_0000616"],"linkedTargets":{"rows":["ENSG00000109163"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0003869","EFO_0000545","EFO_1001757","EFO_0001065","MONDO_0008170","MONDO_0007254","MONDO_0000521","MONDO_0002087","Orphanet_481","EFO_0000305","MONDO_0008315","EFO_0001663","EFO_0000195","EFO_0000304","MONDO_0002158","EFO_0000553","EFO_0006861","EFO_0000731","HP_0008209","EFO_0000673","EFO_0000196","EFO_0000183","MONDO_0024880","EFO_0003922"],"count":25},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1989 and is indicated for neoplasm and has 12 investigational indications."}
{"id":"CHEMBL1201341","canonicalSmiles":"CCOP(=O)(OCC)SCC[N+](C)(C)C","inchiKey":"BJOLKYGKSZKIGU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ECHOTHIOPHATE","yearOfFirstApproval":1960,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Echothiophate","Ecothiopate"],"crossReferences":{"Wikipedia":["Echothiophate"],"drugbank":["DB01057"],"chEBI":["4753"]},"childChemblIds":["CHEMBL1200367"],"count":1,"approvedIndications":["EFO_0000516"],"linkedTargets":{"rows":["ENSG00000087085"],"count":1},"linkedDiseases":{"rows":["HP_0000545","EFO_0000516"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1960 and is indicated for glaucoma."}
{"id":"CHEMBL1201629","drugType":"Protein","blackBoxWarning":false,"name":"INSULIN PURIFIED BEEF","yearOfFirstApproval":1980,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Regular iletin ii"],"synonyms":["Insulin (beef)","Insulin purified beef"],"crossReferences":{"DrugCentral":["5192"]},"count":1,"approvedIndications":["EFO_0000400"],"linkedTargets":{"rows":["ENSG00000171105"],"count":1},"linkedDiseases":{"rows":["EFO_0000400"],"count":1},"description":"Protein drug with a maximum clinical trial phase of IV that was first approved in 1980 and is indicated for diabetes mellitus."}
{"id":"CHEMBL1201837","drugType":"Protein","blackBoxWarning":true,"name":"ECALLANTIDE","yearOfFirstApproval":2009,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["DX-88","Ecallantide"],"crossReferences":{"DailyMed":["ecallantide"],"DrugCentral":["4846"],"Wikipedia":["Ecallantide"]},"count":2,"approvedIndications":["Orphanet_91378"],"linkedTargets":{"rows":["ENSG00000164344"],"count":1},"linkedDiseases":{"rows":["EFO_0005532","Orphanet_91378"],"count":2},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2009 and is indicated for hereditary angioedema and has 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1214192","canonicalSmiles":"CCC1(C)CC(=O)NC(=O)C1","inchiKey":"ORRZGUBHBVWWOP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BEMEGRIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Megimide"],"synonyms":["Bemegride","Methetharimide"],"crossReferences":{"PubChem":["11112173","144203903"],"Wikipedia":["Bemegride"],"drugbank":["DB13740"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1231519","canonicalSmiles":"O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](COP(=O)(O)O)O2)cc1/C=C/Br","inchiKey":"LKWCVKAHHUJPQO-PIXDULNESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1231519","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04438"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1232077","canonicalSmiles":"N[C@H](C(=O)O)c1ccc(O)cc1","inchiKey":"LJCWONGJFPCTTL-ZETCQYMHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OXFENICINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Oxfenicine","UK-25,842"],"crossReferences":{"PubChem":["144205697","170466530"],"drugbank":["DB04291"],"chEBI":["31755"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1232653","canonicalSmiles":"Cc1cc2nc3c(=O)[nH]c(=O)nc-3n(C[C@H](O)[C@H](O)[C@H](O)CO[P@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@@H](n4cnc5c(N)ncnc54)[C@H](O)[C@@H]3O)c2cc1C","inchiKey":"VWWQXMAJTJZDQX-UYBVJOGSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLAVIN ADENIN DINUCLEOTIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Flavin Adenine Dinucleotide","Flavin adenin dinucleotide"],"crossReferences":{"PubChem":["50112827"],"drugbank":["DB03147"],"chEBI":["16238"]},"childChemblIds":["CHEMBL2356834"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1233316","canonicalSmiles":"N[C@H]1C(C(=O)O)=CC=C[C@@H]1O","inchiKey":"XBTXTLKLSHACSS-WDSKDSINSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1233316","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02124"],"chEBI":["60844"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1233584","canonicalSmiles":"CC[C@H](C)[C@H](N)C(=O)O","inchiKey":"AGPKZVBTJJNPAG-WHFBIAKZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ISOLEUCINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Isoleucine","L-isoleucine"],"crossReferences":{"drugbank":["DB00167"],"chEBI":["17191"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL1234081","canonicalSmiles":"CCCCCCCCCCCCCC[C@H](O)OC[C@@H](O)CO[P@](=O)(O)OC[C@H](N)C(=O)O","inchiKey":"RPZLJDFLPRHXGM-HSALFYBXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1234081","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04136"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL123440","canonicalSmiles":"C=CCN(C(=O)c1cc(Cl)cc(OCCCONC(=N)N)c1)C1CCCC1","inchiKey":"XWIUMAPBZWNFNV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL123440","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06859"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1237024","drugType":"Cell","blackBoxWarning":false,"name":"SIPULEUCEL-T","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Provenge"],"synonyms":["APC-8015","APC8015","Sipuleucel-t"],"crossReferences":{"Wikipedia":["Sipuleucel-T"]},"count":3,"approvedIndications":["MONDO_0008315"],"linkedTargets":{"rows":["ENSG00000014257"],"count":1},"linkedDiseases":{"rows":["EFO_0000196","EFO_0000673","MONDO_0008315"],"count":3},"description":"Cell drug with a maximum clinical trial phase of IV (across all indications) and is indicated for prostate cancer and has 2 investigational indications."}
{"id":"CHEMBL125236","canonicalSmiles":"CC(=O)Nc1ccc(OC[C@](C)(O)C(=O)Nc2ccc([N+](=O)[O-])c(C(F)(F)F)c2)cc1","inchiKey":"YVXVTLGIDOACBJ-SFHVURJKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL125236","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"Wikipedia":["Andarine"],"drugbank":["DB07423"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1255901","canonicalSmiles":"C/C=C1\\[C@H]2C=C(C)C[C@@]1(N)c1ccc(=O)[nH]c1C2","inchiKey":"ZRJBHWIHUMBLCN-HZRLMBICSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HUPERZINE A","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Huperzine a"],"count":4,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL1256771","canonicalSmiles":"CCN(CC)CCNC(=O)c1cc(Cl)c(N)cc1OC.Cl","inchiKey":"RVFUNJWWXKCWNS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METOCLOPRAMIDE HYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL86","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AHR-3070-C"],"crossReferences":{"PubChem":["50106586","56422906","855988"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL127643","canonicalSmiles":"CCCCc1cc2ccccc2c(OCCN(C)C)n1","inchiKey":"XNMYNYSCEJBRPZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIMETHISOQUIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Quinisocaine"],"crossReferences":{"PubChem":["11112524"],"Wikipedia":["Quinisocaine"],"drugbank":["DB13683"]},"childChemblIds":["CHEMBL1533364"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1276663","canonicalSmiles":"CO/N=C(\\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(C[n+]3ccn4ncccc43)CS[C@H]12)c1nsc(N)n1","inchiKey":"QDUIJCOKQCCXQY-WHJQOFBOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFOZOPRAN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cefozopran"],"crossReferences":{"Wikipedia":["Cefozopran"],"drugbank":["DB13667"],"chEBI":["3502"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1291","canonicalSmiles":"CC(=O)Oc1c(C)cc(OCC(O)CNC(C)C)c(C)c1C","inchiKey":"BQIPXWYNLPYNHW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METIPRANOLOL","yearOfFirstApproval":1989,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United Kingdom"],"classes":["Opthalmic toxicity"],"year":1990},"tradeNames":["Glauline","Optipranolol"],"synonyms":["BM-01004","BM01.004","Metipranolol","Optipranolol","VUAB-6453","VUAB6453 (SPOFA)"],"crossReferences":{"PubChem":["144205272","29215465"],"Wikipedia":["Metipranolol"],"drugbank":["DB01214"],"chEBI":["6897"]},"childChemblIds":["CHEMBL1200947"],"count":1,"approvedIndications":["EFO_0000516"],"linkedTargets":{"rows":["ENSG00000169252","ENSG00000043591"],"count":2},"linkedDiseases":{"rows":["EFO_0000516"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1989 and is indicated for glaucoma. It was withdrawn in United Kingdom  in 1990 due to Opthalmic toxicity."}
{"id":"CHEMBL1303","canonicalSmiles":"CCCN(CCc1cccs1)[C@H]1CCc2c(O)cccc2C1","inchiKey":"KFQYTPMOWPVWEJ-INIZCTEOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ROTIGOTINE","yearOfFirstApproval":2007,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Neupro"],"synonyms":["Rotigotine","SPM 962","SPM-962"],"crossReferences":{"DailyMed":["rotigotine"],"PubChem":["144206180","170465204","50113269"],"Wikipedia":["Rotigotine"],"drugbank":["DB05271"]},"count":5,"approvedIndications":["EFO_0002508","EFO_0004270"],"linkedTargets":{"rows":["ENSG00000069696","ENSG00000149295","ENSG00000151577"],"count":3},"linkedDiseases":{"rows":["EFO_0005687","EFO_0002508","EFO_0000712","EFO_0000249","EFO_0004270","EFO_0003843"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2007 and is indicated for parkinson's disease and restless legs syndrome and has 3 investigational indications."}
{"id":"CHEMBL130865","canonicalSmiles":"NC(C(=O)O)c1ccc(O)cc1","inchiKey":"LJCWONGJFPCTTL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"D-26","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["D-26"],"crossReferences":{"drugbank":["DB02601"],"chEBI":["50418"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1421212","canonicalSmiles":"COCC(=O)O[C@]1(CCN(C)CCCc2nc3ccccc3[nH]2)CCc2cc(F)ccc2[C@@H]1C(C)C.Cl.O","inchiKey":"WTEKKBNMVUOLJX-GDUXWEAWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1421212","maximumClinicalTrialPhase":0,"parentId":"CHEMBL45816","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["26732644"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1489254","canonicalSmiles":"CC(=O)OCC(COC(C)=O)OC(C)=O","inchiKey":"URAYPUMNDPQOKB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIACETIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Eastman triacetin","Enzactin"],"synonyms":["E1518","FEMA NO. 2007","Glyceryl triacetate","NSC-4796","Triacetin"],"crossReferences":{"PubChem":["144204706","144208943","144210431","170465543","17388686","26747385","26753075","56462778"],"Wikipedia":["Triacetin"],"chEBI":["9661"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1514715","canonicalSmiles":"CCNCC.O=S(=O)(O)c1cc(O)ccc1O","inchiKey":"HBGOLJKPSFNJSD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETHAMSYLATE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL1232131","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dicynene","Dicynene 1000","Dicynone"],"synonyms":["E 141","E-141","Etamsilate","Etamsylate","Ethamsylate","MD 141","MD-141"],"crossReferences":{"DrugCentral":["1075"],"PubChem":["11112957","144204303"],"drugbank":["DB13483"]},"count":2,"approvedIndications":["MP_0001914"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for hemorrhage and has 1 investigational indication."}
{"id":"CHEMBL1520","canonicalSmiles":"CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12","inchiKey":"SECKRCOLJRRGGV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VARDENAFIL","yearOfFirstApproval":2003,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Levitra"],"synonyms":["BAY-389456","BAY38-9456","Vardenafil"],"crossReferences":{"DailyMed":["vardenafil%20hydrochloride"],"Wikipedia":["Vardenafil"],"drugbank":["DB00862"],"chEBI":["46295"]},"childChemblIds":["CHEMBL2106480","CHEMBL1874590","CHEMBL1339"],"count":8,"approvedIndications":["EFO_0004234"],"linkedTargets":{"rows":["ENSG00000138735"],"count":1},"linkedDiseases":{"rows":["MONDO_0005149","EFO_0000765","EFO_0001361","HP_0000360","EFO_0002687","EFO_0004234","HP_0000802","Orphanet_586","EFO_1000781","EFO_0000284","EFO_1001145"],"count":11},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2003 and is indicated for erectile dysfunction and has 7 investigational indications."}
{"id":"CHEMBL153036","canonicalSmiles":"CNCC[C@@H](Oc1ccc(C(F)(F)F)cc1)c1ccccc1","inchiKey":"RTHCYVBBDHJXIQ-MRXNPFEDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"R-FLUOXETINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fluoxetine"],"crossReferences":{"PubChem":["50111060"],"drugbank":["DB08472"],"chEBI":["86991"]},"childChemblIds":["CHEMBL1256757"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1531817","canonicalSmiles":"Cl.Nc1nc2ccc(OC(F)(F)F)cc2s1","inchiKey":"QEAOELIJQRYJJS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1531817","maximumClinicalTrialPhase":0,"parentId":"CHEMBL744","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["26719750"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1541","canonicalSmiles":"C=CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)/C(=N\\OCC(=O)O)c3csc(N)n3)[C@H]2SC1","inchiKey":"OKBVVJOGVLARMR-QSWIMTSFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFIXIME","yearOfFirstApproval":1989,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cefixime","Cefspan","Oroken","Suprax"],"synonyms":["CL 284,635","CL-284635","Cefixime","Cefixime hydrate","Cefixime trihydrate","FK 027","FK-027","FR 17027","FR-17027"],"crossReferences":{"DailyMed":["cefixime"],"PubChem":["85148376"],"Wikipedia":["Cefixime"],"drugbank":["DB00671"],"chEBI":["472657"]},"count":11,"approvedIndications":["HP_0012388","EFO_0000771","EFO_0000544","EFO_0004992","HP_0011110","MONDO_0002258"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1989 and has 6 approved and 5 investigational indications."}
{"id":"CHEMBL15594","canonicalSmiles":"CCCCC/C=C\\C/C=C\\C/C=C\\C/C=C\\CCCC(=O)O","inchiKey":"YZXBAPSDXZZRGB-DOFZRALJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ARACHIDONIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Arachidonic acid","Cis-5,8,11,14-Eicosatetraenoic Acid"],"crossReferences":{"PubChem":["26747902","26753719","57261284"],"Wikipedia":["Arachidonic_acid"],"drugbank":["DB04557"],"chEBI":["15843"]},"childChemblIds":["CHEMBL3274190"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL156987","canonicalSmiles":"O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1","inchiKey":"ONVZFCHLOZUXRP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SB-409513","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SB-409513"],"crossReferences":{"PubChem":["124349840"],"drugbank":["DB01793"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1620794","canonicalSmiles":"CCN(CC)CCOC(=O)C(Cc1cccc2ccccc12)CC1CCCO1","inchiKey":"KBAFPSLPKGSANY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NAFRONYL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Naftidrofuryl"],"crossReferences":{"drugbank":["DB13588"]},"childChemblIds":["CHEMBL1439099"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1626570","canonicalSmiles":"COS(=O)(=O)[O-].C[N+]1(C)CCN(CC(O)(c2ccccc2)C2CCCCC2)CC1","inchiKey":"NSILVESQCSUIAJ-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"HEXOCYCLIUM METHYLSULFATE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201325","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tral"],"synonyms":["Hexocyclium methylsulfate","Hexocyclium metilsulfate"],"crossReferences":{"PubChem":["144206775"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1651905","canonicalSmiles":"O=C(COCCOCCOCC(=O)Nc1c(I)cc(I)c(C(=O)O)c1I)Nc1c(I)cc(I)c(C(=O)O)c1I","inchiKey":"JXMIBUGMYLQZGO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IOTROXIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Iotroxic acid","SH 213 AB"],"crossReferences":{"PubChem":["144206809"],"drugbank":["DB08945"]},"childChemblIds":["CHEMBL4297078"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1725","canonicalSmiles":"COCC(=O)Nc1c(I)c(C(=O)NCC(O)CO)c(I)c(C(=O)N(C)CC(O)CO)c1I","inchiKey":"DGAIEPBNLOQYER-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"IOPROMIDE","yearOfFirstApproval":1995,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ultravist","Ultravist (pharmacy bulk)","Ultravist 150","Ultravist 240","Ultravist 300","Ultravist 370"],"synonyms":["Iopromide","ZK 35760","ZK-35760"],"crossReferences":{"PubChem":["170465023","56463063"],"Wikipedia":["Iopromide"],"drugbank":["DB09156"],"chEBI":["63578"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1995. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1742439","canonicalSmiles":"CN(C)CCn1nc(Cc2ccccc2)c2ccccc2c1=O","inchiKey":"LCAAMXMULMCKLJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TALASTINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Talastine"],"crossReferences":{"drugbank":["DB13349"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1743259","canonicalSmiles":"CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CC","inchiKey":"IZBNNCFOBMGTQX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETOPERIDONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Etoperidone"],"crossReferences":{"drugbank":["DB09194"]},"childChemblIds":["CHEMBL3085482"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL184410","canonicalSmiles":"OCc1ccc(Br)cc1","inchiKey":"VEDDBHYQWFOITD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL184410","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02822"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL18851","canonicalSmiles":"[2H]C([2H])(CC(=O)O)C(=O)CN","inchiKey":"ZGXJTSGNIOSYLO-DICFDUPASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL18851","maximumClinicalTrialPhase":0,"parentId":"CHEMBL601","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL189607","canonicalSmiles":"Nc1nc2ccc(C(=O)c3c(F)cccc3F)cn2c1C(=O)c1ccccc1","inchiKey":"WUGJIPFLBOATGL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL189607","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04006"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1908318","canonicalSmiles":"CC(=O)N[C@H]1[C@H](NC(=O)C[C@@H]2NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]3CNC(=O)C[C@H](NC2=O)C(=O)N[C@@H](Cc2c[nH]c4ccccc24)C(=O)N[C@@H](Cc2ccccc2)C(=O)N3)O[C@H](CO)[C@@H](O)[C@@H]1O","inchiKey":"NGCNKEZHGRXHNL-WVWQGFTISA-N","drugType":"Protein","blackBoxWarning":false,"name":"NEPADUTANT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Nepadutant"],"crossReferences":{"drugbank":["DB12538"]},"count":1,"description":"Protein drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1908319","canonicalSmiles":"C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3C=C[C@@]21C","inchiKey":"GVDMJXQHPUYPHP-FYQPLNBISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NORGESTRIENONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Norgestrienone"],"crossReferences":{"drugbank":["DB13563"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1909079","drugType":"Small molecule","blackBoxWarning":false,"name":"STANNOUS FLUORIDE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Omnigel","Stop"],"synonyms":["Stannous fluoride"],"count":2,"approvedIndications":["MONDO_0002508"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for gingivitis and has 1 investigational indication."}
{"id":"CHEMBL191275","canonicalSmiles":"O=C(O)[C@H](Cc1ccccc1)Oc1ccc(-c2ccccc2)cc1","inchiKey":"TZTPJJNNACUQQR-FQEVSTJZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL191275","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08121"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL193156","canonicalSmiles":"c1ccc2c(CCc3ccncc3)c[nH]c2c1","inchiKey":"UUEYCHLWAOBOHG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL193156","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01953"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2003538","canonicalSmiles":"CCCCCCCCCCCCCCCC[n+]1ccccc1.O.[Cl-]","inchiKey":"NFCRBQADEGXVDL-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CETYLPYRIDINIUM CHLORIDE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL305906","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ceepryn","Cepacol","Gppe dental rinse","Gppe oral liq","Merocet","Merocets","Merocets plus","Merovit","Search","Steradent"],"synonyms":["Cetylpyridinium chloride","Cetylpyridinium chloride hydrate","Cetylpyridinium chloride monohydrate","NB-002","NSC-14864"],"crossReferences":{"PubChem":["103076120"],"chEBI":["3566"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2027925","canonicalSmiles":"Nc1c(Cl)cc(-c2nn(C3CCN(CCc4ccccc4)CC3)c(=O)o2)c2c1OCCO2","inchiKey":"MDBNTXARNGRHEV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CAPESEROD","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Capeserod","SL650155","Sl65.0155"],"childChemblIds":["CHEMBL2022742"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL204459","canonicalSmiles":"N[C@H](C(=O)N1CC(c2cc(F)ccc2F)=C[C@H]1c1ccccc1)C1CC1","inchiKey":"VCOUEHUEFUDZIS-PMACEKPBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL204459","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08244"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL205786","canonicalSmiles":"Cc1ccc2c(c1C)CN(C(=O)N(C)C)C[C@@H]2c1cccc(O)c1","inchiKey":"HPVCRUIDFODATB-LJQANCHMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL205786","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07064"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2064455","canonicalSmiles":"Nc1ccn([C@@H]2C(F)=C(CO)[C@@H](O)[C@H]2O)c(=O)n1","inchiKey":"QLLGKCJUPWYJON-HLTSFMKQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RODUCITABINE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fluorocyclopentenylcytosine","RX-3117","Roducitabine","Rx-3117","TV-1360"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2068839","canonicalSmiles":"Cc1ccc(COC(=O)N2CC[C@H](CNc3ncccn3)[C@H](F)C2)cc1","inchiKey":"RECBFDWSXWAXHY-IAGOWNOFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RISLENEMDAZ","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CERC-301","Cerc-301","MK-0657","MK-0657, (-)-","Rislenemdaz"],"crossReferences":{"drugbank":["DB12063"]},"childChemblIds":["CHEMBL2036513"],"count":2,"linkedTargets":{"rows":["ENSG00000273079","ENSG00000176884"],"count":2},"linkedDiseases":{"rows":["MONDO_0002050","MONDO_0002009"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2103740","drugType":"Small molecule","blackBoxWarning":true,"name":"GADOXETATE DISODIUM","yearOfFirstApproval":2008,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2221312","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Eovist"],"synonyms":["Gadoxetate disodium","Gadoxetate sodium","Gadoxetic acid sodium salt","SHL-569B","ZK 139834","ZK-139834"],"crossReferences":{"DailyMed":["gadoxetate%20disodium"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2008. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2103817","canonicalSmiles":"CCNC1(C(N)=O)CCN(c2ncnc3c2nc(-c2ccccc2Cl)n3-c2ccc(Cl)cc2)CC1.Cl","inchiKey":"KPYUQCJBZGQHPL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OTENABANT HYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL562668","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CP-945,598","CP-945598","Otenabant hydrochloride"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2103836","canonicalSmiles":"CCC[C@@H](C)C[C@H](N)CC(=O)O","inchiKey":"JXEHXYFSIOYTAH-SFYZADRCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IMAGABALIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Imagabalin","PD 0332334","PD-0332334","PF-00195889"],"crossReferences":{"drugbank":["DB12105"]},"childChemblIds":["CHEMBL2105673"],"count":2,"linkedTargets":{"rows":["ENSG00000075461","ENSG00000157388","ENSG00000142408","ENSG00000157445","ENSG00000165995","ENSG00000100346","ENSG00000151067","ENSG00000166862","ENSG00000148408","ENSG00000198216","ENSG00000105605","ENSG00000167535","ENSG00000006116","ENSG00000007402","ENSG00000081248","ENSG00000102001","ENSG00000151062","ENSG00000006283","ENSG00000141837","ENSG00000108878","ENSG00000075429","ENSG00000182389","ENSG00000130433","ENSG00000196557","ENSG00000153956","ENSG00000067191"],"count":26},"linkedDiseases":{"rows":["HP_0000083","EFO_1001892","EFO_0005230"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2104595","canonicalSmiles":"OC(CO/N=C(\\Cl)c1cccnc1)CN1CCCCC1","inchiKey":"NMOVJBAGBXIKCG-VKAVYKQESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BIMOCLOMOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bimoclomol"],"crossReferences":{"drugbank":["DB06258"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2104739","canonicalSmiles":"CS(=O)(=O)[O-].C[n+]1ccccc1C=NO","inchiKey":"WWZYJJGFUIAWNW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PRALIDOXIME MESYLATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1420","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pralidoxime mesylate"],"crossReferences":{"chEBI":["50240"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105606","canonicalSmiles":"CCCC(=O)C1=C(O)C(C)(C)C(O)=C(Cc2c(OC)cc(O)c(C(=O)CCC)c2O)C1=O","inchiKey":"GAHOBHHMYUYJDT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DESASPIDIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Desaspidin"],"crossReferences":{"drugbank":["DB13567"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2105617","canonicalSmiles":"CCC1C2CC3C4N(C)c5ccccc5C45CC(C2[C@H]5O)N3C1O","inchiKey":"CJDRUOGAGYHKKD-FUIWMBJSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AJMALINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ajmaline","NSC-15627"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2105733","canonicalSmiles":"CNCc1ccc(-c2[nH]c3cc(F)cc4c3c2CCNC4=O)cc1.O=P(O)(O)O","inchiKey":"FCCGJTKEKXUBFZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RUCAPARIB PHOSPHATE","maximumClinicalTrialPhase":1,"parentId":"CHEMBL1173055","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AG-014699","AG-14699","AG014699","PF-01367338","PF01367338","Rucaparib phosphate"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2107084","canonicalSmiles":"Cn1c(=O)c2[nH]cnc2n(C)c1=O.NCCO","inchiKey":"DAAFJZUNCOXSKD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"THEOPHYLLINE OLAMINE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL190","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Theophylline olamine"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2107691","canonicalSmiles":"COC(CN1CCN(CCC(O)c2ccccc2)CC1)c1ccccc1","inchiKey":"QSRHLIUOSXVKTG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EPROZINOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Eprozinol"],"crossReferences":{"drugbank":["DB13395"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2107767","canonicalSmiles":"FC(F)(F)c1cccc(C2=CCN(CCc3ccc(-c4ccccc4)cc3)CC2)c1","inchiKey":"CNEWKIDCGDXBDE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PALIRODEN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Paliroden","SR5-7667B","SR57667B","Sr57667b"],"crossReferences":{"drugbank":["DB05454"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2107784","canonicalSmiles":"COc1cccc2c1c(O)c(C(=O)N(C)c1ccc(C(F)(F)F)cc1)c(=O)n2C","inchiKey":"ONDYALNGTUAJDX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TASQUINIMOD","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tasquinimod"],"crossReferences":{"Wikipedia":["Tasquinimod"],"drugbank":["DB05861"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2107997","drugType":"Unknown","blackBoxWarning":false,"name":"SIZOFIRAN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Sizofiran","Sonifilan"],"crossReferences":{"DrugCentral":["4048"]},"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2108085","drugType":"Protein","blackBoxWarning":false,"name":"SULGLICOTIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Sulglicotide","Sulglycotide"],"crossReferences":{"DrugCentral":["4725"]},"count":2,"description":"Protein drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2108185","drugType":"Protein","blackBoxWarning":false,"name":"CORIFOLLITROPIN ALFA","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Elonva"],"synonyms":["Corifollitropin alfa","MK-8962","ORG 36286","ORG-36286","SCH 900962","SCH-900962"],"count":2,"linkedTargets":{"rows":["ENSG00000170820"],"count":1},"linkedDiseases":{"rows":["EFO_0000545","EFO_0001073","MONDO_0018555"],"count":3},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2108312","drugType":"Protein","blackBoxWarning":false,"name":"OZARELIX","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["D-63153","D63153","Ozarelix"],"count":2,"linkedTargets":{"rows":["ENSG00000109163"],"count":1},"linkedDiseases":{"rows":["EFO_0000284","MONDO_0008315"],"count":2},"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2108591","drugType":"Antibody","blackBoxWarning":false,"name":"ELSILIMOMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["B-e8"],"synonyms":["Elsilimomab"],"description":"Antibody drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2108675","drugType":"Antibody","blackBoxWarning":false,"name":"DUPILUMAB","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dupixent","Regn668, sar231893"],"synonyms":["Dupilumab","REGN-668","REGN668","SAR-231893","SAR231893"],"crossReferences":{"DailyMed":["dupilumab"]},"count":21,"approvedIndications":["HP_0000964","EFO_0000274"],"linkedTargets":{"rows":["ENSG00000077238"],"count":1},"linkedDiseases":{"rows":["EFO_0005854","HP_0000989","EFO_1000668","EFO_0007486","EFO_0007425","HP_0000964","EFO_0010638","EFO_0007140","EFO_0000274","EFO_0005532","EFO_1002029","HP_0012042","MONDO_0008315","Orphanet_634","EFO_0007187","EFO_0004232","EFO_0005531","EFO_1000740","EFO_0000684","EFO_1000391","EFO_0004192","EFO_0000270","MONDO_0002406","EFO_1001361","EFO_0000341","EFO_0007141"],"count":26},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2017 and is indicated for eczema and atopic eczema and has 19 investigational indications."}
{"id":"CHEMBL2108806","drugType":"Oligosaccharide","blackBoxWarning":false,"name":"BEMIPARIN SODIUM","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Zibor"],"synonyms":["Bemiparin sodium"],"count":1,"linkedTargets":{"rows":["ENSG00000117601"],"count":1},"linkedDiseases":{"rows":["EFO_0000545","MONDO_0100096","EFO_0003907"],"count":3},"description":"Oligosaccharide drug with a maximum clinical trial phase of IV and has 1 investigational indication."}
{"id":"CHEMBL2109070","drugType":"Unknown","blackBoxWarning":false,"name":"LACTOBACILLUS ACIDOPHILUS","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Gynatren"],"synonyms":["Lactobacillus acidophilus","Lactomin"],"count":16,"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) and has 16 investigational indications."}
{"id":"CHEMBL2109284","drugType":"Antibody","blackBoxWarning":false,"name":"CMB-401","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CMB-401","HCTMO1-CALICHEAMICIN"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2109306","drugType":"Antibody","blackBoxWarning":false,"name":"LMB-1","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LMB-1"],"description":"Antibody drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2109382","drugType":"Antibody","blackBoxWarning":false,"name":"MEDI-639","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MEDI-639"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2109423","drugType":"Antibody","blackBoxWarning":false,"name":"MAB-3F8","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MAB-3F8","Mab-3f8"],"count":1,"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2109642","drugType":"Antibody","blackBoxWarning":false,"name":"A33 131I","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["A33","A33 131i"],"count":1,"linkedTargets":{"rows":["ENSG00000143167"],"count":1},"linkedDiseases":{"rows":["EFO_1001951"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2110760","canonicalSmiles":"CCN(CCO)CCn1c(Cc2ccccc2)nc2c1c(=O)n(C)c(=O)n2C","inchiKey":"VVUYEFBRTFASAH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BAMIFYLLINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bamifylline"],"crossReferences":{"drugbank":["DB13203"]},"childChemblIds":["CHEMBL2105899"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2110849","canonicalSmiles":"CC(C)N(CCC(c1ccccc1)c1ccccc1)C(C)C","inchiKey":"YBJKOPHEJOMRMN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIISOPROMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Diisopromine"],"crossReferences":{"drugbank":["DB13476"]},"childChemblIds":["CHEMBL2106314"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL21333","canonicalSmiles":"O=C(Nc1cccc2c(=O)cc(-c3nn[nH]n3)oc12)c1ccc(OCCCCc2ccccc2)cc1","inchiKey":"NBQKINXMPLXUET-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PRANLUKAST","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CCN 00401","CCN-00401","ONO 1078","ONO-1078","Pranlukast","RS 411","RS-411","SB 205312","SB-205312"],"crossReferences":{"PubChem":["144206505"],"Wikipedia":["Pranlukast"],"drugbank":["DB01411"]},"childChemblIds":["CHEMBL3810125"],"count":3,"linkedTargets":{"rows":["ENSG00000173198"],"count":1},"linkedDiseases":{"rows":["HP_0006536","EFO_0007486","EFO_0003956"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL214205","canonicalSmiles":"NCCN1CCOCC1","inchiKey":"RWIVICVCHVMHMU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"2-Morpholinoethanamine","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-Morpholinoethanamine"],"crossReferences":{"PubChem":["144212388"],"drugbank":["DB03096"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL214268","canonicalSmiles":"O=C(N[C@H]1CN2CCC1CC2)c1cc2ccoc2cn1","inchiKey":"IPKZCLGGYKRDES-ZDUSSCGKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHA-543613","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PHA-543613","Pha-543613"],"crossReferences":{"PubChem":["144210766"],"Wikipedia":["PHA-543,613"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2221312","drugType":"Small molecule","blackBoxWarning":true,"name":"GADOXETIC ACID","yearOfFirstApproval":2008,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Gadoxetic acid"],"crossReferences":{"DailyMed":["gadoxetate%20disodium"],"DrugCentral":["3259","4646"]},"childChemblIds":["CHEMBL2103740"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2008. This drug has a black box warning from the FDA."}
{"id":"CHEMBL22498","canonicalSmiles":"CC(Cc1ccccc1)NN","inchiKey":"VXTWEDPZMSVFEF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENIPRAZINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pheniprazine"],"crossReferences":{"Wikipedia":["Pheniprazine"],"drugbank":["DB09250"]},"childChemblIds":["CHEMBL2106542"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2356097","canonicalSmiles":"COCCc1ccc(OCC(O)CNC(C)C)cc1.COCCc1ccc(OCC(O)CNC(C)C)cc1.O=C(O)CCC(=O)O","inchiKey":"RGHAZVBIOOEVQX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"METOPROLOL SUCCINATE","yearOfFirstApproval":1992,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL13","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Kapspargo sprinkle","Metoprolol succinate","Toprol","Toprol Xl","Toprol-xl"],"synonyms":["H 93/26 SUCCINATE","Metoprolol succinate"],"crossReferences":{"DailyMed":["metoprolol%20succinate"],"PubChem":["144206706"]},"count":10,"approvedIndications":["EFO_0003144","EFO_0000373","EFO_0000537","EFO_0003913"],"linkedTargets":{"rows":["ENSG00000043591"],"count":1},"linkedDiseases":{"rows":["EFO_0000275","EFO_0000373","EFO_0000266","EFO_0000538","EFO_0009094","EFO_0000537","EFO_0003913","EFO_0008585","Orphanet_79292","EFO_0003144","EFO_0008583","EFO_1002032","EFO_0000341","EFO_0008586","HP_0001653"],"count":15},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1992 and has 4 approved and 6 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2364612","canonicalSmiles":"O=C(CCC/C=C\\C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCc1ccccc1)OCCCCO[N+](=O)[O-]","inchiKey":"LOVMMUBRQUFEAH-UIEAZXIASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LATANOPROSTENE BUNOD","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Vesneo","Vyzulta"],"synonyms":["BOL-303259-X","Bol-303259-x","Latanoprostene bunod","NCX 116","NCX-116","PF-3187207"],"crossReferences":{"DailyMed":["latanoprostene%20bunod"],"drugbank":["DB11660"]},"count":3,"approvedIndications":["EFO_0004190","EFO_1001069","EFO_0000516"],"linkedTargets":{"rows":["ENSG00000122420"],"count":1},"linkedDiseases":{"rows":["EFO_0004190","EFO_1001069","EFO_0000516"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2017 and has 3 approved indications."}
{"id":"CHEMBL237600","canonicalSmiles":"C=CC(=O)c1ccc(CCCCCC)cc1","inchiKey":"IINHTEWASPUCMH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL237600","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["29217563","90341136"],"drugbank":["DB08085"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL249420","canonicalSmiles":"CCCN[C@@H]1CCc2nc(N)sc2C1","inchiKey":"FASDKYOPVNHBLU-SSDOTTSWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEXPRAMIPEXOLE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dexpramipexole"],"crossReferences":{"drugbank":["DB15130"]},"childChemblIds":["CHEMBL2105687","CHEMBL3216394"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL26215","canonicalSmiles":"CCCCCCCCO","inchiKey":"KBPLFHHGFOOTCA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OCTANOL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["1-Octanol","Octan-1-ol","Octanol"],"crossReferences":{"PubChem":["144208571","144210416","17389591","26752869","26752870","49732778"],"Wikipedia":["Octanol"],"drugbank":["DB12452"],"chEBI":["16188"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL268291","canonicalSmiles":"CN(C)C=O","inchiKey":"ZMXDDKWLCZADIW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIMETHYLFORMAMIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144208457","17388882","17389908","26752801"],"Wikipedia":["Dimethylformamide"],"drugbank":["DB01844"],"chEBI":["17741"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL268501","canonicalSmiles":"Cc1ccc2c(-c3ccccc3)nc(=O)n(C(C)C)c2c1","inchiKey":"JTIGKVIOEQASGT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROQUAZONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Arthrex"],"synonyms":["43-715","Proquazone"],"crossReferences":{"Wikipedia":["Proquazone"],"drugbank":["DB13649"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL269538","canonicalSmiles":"COc1ccc2c(c1)[nH]c1c(C)nccc12","inchiKey":"BXNJHAXVSOCGBA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HARMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["11112332","118045984","124360166","124882255","124882257","124882258","124882259","26748430","26753728","26753729","50107399","85239699"],"Wikipedia":["Harmine"],"drugbank":["DB07919"],"chEBI":["28121"]},"childChemblIds":["CHEMBL486818","CHEMBL1593867"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL288376","drugType":"Small molecule","blackBoxWarning":false,"name":"CARBOPLATINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Carboplatine","Paraplatin"],"crossReferences":{"PubChem":["144206139","170464868","50112939","568180"],"Wikipedia":["Carboplatin"]},"childChemblIds":["CHEMBL13216"],"count":8,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL29024","canonicalSmiles":"CC(C)(C)c1snc(O)c1C[C@H](N)C(=O)O","inchiKey":"FHWOAQCPEFTDOQ-LURJTMIESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL29024","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04798"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL292963","canonicalSmiles":"O=C1C[C@@]2(C(=O)N1)C(=O)N(Cc1ccc(Br)cc1F)C(=O)c1ccc(F)cc12","inchiKey":"BMHZAHGTGIZZCT-LJQANCHMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Minalrestat","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Minalrestat"],"crossReferences":{"drugbank":["DB07450"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL297453","canonicalSmiles":"O=C(O[C@@H]1Cc2c(O)cc(O)cc2O[C@@H]1c1cc(O)c(O)c(O)c1)c1cc(O)c(O)c(O)c1","inchiKey":"WMBWREPUVVBILR-WIYYLYMNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EPIGALOCATECHIN GALLATE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(-)-Epigallocatechin Gallate","Epigalocatechin gallate"],"crossReferences":{"PubChem":["144208666","144213767","26719730","26757738","49681655"],"Wikipedia":["Epigallocatechin_gallate"],"drugbank":["DB12116"],"chEBI":["4806"]},"count":37,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 37 investigational indications."}
{"id":"CHEMBL3039594","canonicalSmiles":"CNC(C)[C@@H]1CC[C@@H](N)[C@@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H]2O)O1.CN[C@@H]1[C@@H](O)[C@@H](O[C@@H]2[C@@H](O)[C@H](O[C@H]3O[C@H](C(C)N)CC[C@H]3N)[C@@H](N)C[C@H]2N)OC[C@]1(C)O.CN[C@@H]1[C@@H](O)[C@@H](O[C@@H]2[C@@H](O)[C@H](O[C@H]3O[C@H](CN)CC[C@H]3N)[C@@H](N)C[C@H]2N)OC[C@]1(C)O.O=S(=O)(O)O","inchiKey":"RDEIXVOBVLKYNT-VQBXQJRRSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"GENTAMICIN SULFATE","yearOfFirstApproval":1970,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL3039597","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Apogen","Bristagen","Cidomycin","Cidomycin intrathecal","Garamycin","Genoptic","Gentacidin","Gentafair","Gentak","Gentamicin sulfate","Genticin","Genticin intrathecal","Lugacin","Septopal","U-gencin"],"synonyms":["Gentamicin c complex sulfate","Gentamicin sulfate","Gentamicin sulphate","NSC-82261","SCH 9724","SCH-9724"],"crossReferences":{"DailyMed":["gentamicin%20sulfate"]},"count":10,"approvedIndications":["MP_0001845"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1970 and is indicated for inflammation and has 9 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL306380","canonicalSmiles":"Cc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1","inchiKey":"ZVPDNRVYHLRXLX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL306380","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["103904783","17402282","26756734","26756735"],"drugbank":["DB01809"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3085436","canonicalSmiles":"NCCC[C@H](N)CC(=O)N[C@H]1CNC(=O)[C@H]([C@H]2C[C@H](O)NC(N)=N2)NC(=O)/C(=C/NC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC1=O","inchiKey":"GXFAIFRPOKBQRV-GHXCTMGLSA-N","drugType":"Protein","blackBoxWarning":false,"name":"VIOMYCIN","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Viomycin"],"crossReferences":{"drugbank":["DB06827"],"chEBI":["15782"]},"childChemblIds":["CHEMBL3989823"],"description":"Protein drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL3085474","canonicalSmiles":"N=C(N)c1ccc(-c2ccc(OC[C@@H]3C[C@@H](CC(=O)O)C(=O)N3)cc2)cc1","inchiKey":"IKZACQMAVUIGPY-HOTGVXAUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FRADAFIBAN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fradafiban"],"crossReferences":{"drugbank":["DB06472"],"chEBI":["73266"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3093129","canonicalSmiles":"Nc1ccccc1NC(=O)c1ccc(CN[11C](=O)OCc2cccnc2)cc1","inchiKey":"INVTYAOGFAGBOE-GJQNQZCXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3093129","maximumClinicalTrialPhase":0,"parentId":"CHEMBL27759","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL310671","canonicalSmiles":"O=C1NS(=O)(=O)c2ccccc21","inchiKey":"CVHZOJJKTDOEJC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SACCHARIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Sweeta"],"synonyms":["Benzosulfinide","E-954(I)","E954","Gluside","INS NO.954(I)","INS-954(I)","NSC-5349","Saccharin"],"crossReferences":{"PubChem":["144204911","144209078","144213267","170465766","26748529","26753733"],"Wikipedia":["Saccharin"],"drugbank":["DB12418"],"chEBI":["32111"]},"childChemblIds":["CHEMBL2447917"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL3137319","canonicalSmiles":"NC(=O)c1cccc([C@@H]2C[C@@H]3CC[C@H](C2)N3CCN(CC2CCCCC2)C(=O)[C@@H](O)CO)c1.O=S(=O)(O)O","inchiKey":"QNFFAKFVKCGLPK-WTKDUOFSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AXELOPRAN SULFATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL3137313","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Axelopran sulfate","TD-1211 Sulfate"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3137328","canonicalSmiles":"N[C@H](CCC(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)[O-])C(=O)[O-].[H+].[K+]","inchiKey":"JBUWHGCMOSDECA-LOCPCMAASA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"ORILOTIMOD POTASSIUM","maximumClinicalTrialPhase":2,"parentId":"CHEMBL3137306","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["APO-805K1","Apo805K1","Orilotimod potassium"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL315795","canonicalSmiles":"Cc1ncsc1CCCl","inchiKey":"PCLITLDOTJTVDJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLOMETHIAZOLE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Heminevrin"],"synonyms":["Clomethiazole","SCTZ [AS EDISYLATE]"],"crossReferences":{"PubChem":["11113756","144204482","170466516","26751938","90341262"],"Wikipedia":["Clomethiazole"],"drugbank":["DB06470"]},"count":4,"linkedTargets":{"rows":["ENSG00000145864","ENSG00000166206","ENSG00000163288"],"count":3},"linkedDiseases":{"rows":["MONDO_0002050","HP_0000726","EFO_0005230","EFO_0000692"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL319144","canonicalSmiles":"O=P(O)(O)C(O)(Cc1cnc2ccccn12)P(=O)(O)O","inchiKey":"VMMKGHQPQIEGSQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MINODRONIC ACID","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Minodronic acid","ONO-5920","YM 529","YM-529"],"crossReferences":{"PubChem":["144206806"],"Wikipedia":["Minodronic_acid"],"drugbank":["DB06548"]},"count":2,"linkedTargets":{"rows":["ENSG00000160752"],"count":1},"linkedDiseases":{"rows":["EFO_0003854","EFO_0003882"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL321691","canonicalSmiles":"CCSC(=N)N","inchiKey":"VFIZBHJTOHUOEK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETHYLISOTHIOUREA","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-Ethyl-Isothiourea"],"crossReferences":{"PubChem":["11111141","11113749","50104607","90341019"],"drugbank":["DB02234"]},"childChemblIds":["CHEMBL4531203","CHEMBL1255945"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3218576","canonicalSmiles":"COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21","inchiKey":"PZBCKZWLPGJMAO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"COPANLISIB","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["BAY 80-6946","BAY-80-6946","BAY80-6946","Bay-80-6946","Copanlisib"],"crossReferences":{"DailyMed":["copanlisib%20dihydrochloride"],"drugbank":["DB12483"]},"childChemblIds":["CHEMBL3545068"],"count":15,"approvedIndications":["EFO_0000616"],"linkedTargets":{"rows":["ENSG00000171608","ENSG00000121879"],"count":2},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0044887","EFO_0000403","MONDO_0007254","EFO_1001469","EFO_0005952","EFO_0002426","MONDO_0021063","EFO_0000305","MONDO_0008315","EFO_0005221","EFO_0000304","EFO_0000096","EFO_0000095","EFO_1000238","EFO_1000242","EFO_0000574","MONDO_0018906","EFO_0004606","EFO_0000707","MONDO_0024880","EFO_1000233"],"count":22},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2017 and is indicated for neoplasm and has 14 investigational indications."}
{"id":"CHEMBL3301678","canonicalSmiles":"CCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCC.CCCCCCCC(=O)OCC(O)CO.CCCCCCCCCC(=O)OCC(O)CO.OCC(O)CO","inchiKey":"YTORMSBGFMQNEO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MONOCTANOIN","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL3304484","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Moctanin"],"synonyms":["Capmul 8210","Monoctanoin","Monooctanoin"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1985."}
{"id":"CHEMBL3544940","drugType":"Small molecule","blackBoxWarning":false,"name":"G1T28-1","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["G1t28-1"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545123","canonicalSmiles":"COC(=O)N[C@H](C(=O)N1CCC[C@H]1c1nc2cc([C@H]3CC[C@H](c4cc5nc([C@@H]6CCCN6C(=O)[C@@H](NC(=O)OC)[C@@H](C)OC)[nH]c5cc4F)N3c3cc(F)c(N4CCC(c5ccc(F)cc5)CC4)c(F)c3)c(F)cc2[nH]1)[C@@H](C)OC","inchiKey":"VJYSBPDEJWLKKJ-NLIMODCCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIBRENTASVIR","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["A-1325912.0","ABT-530","Pibrentasvir"],"crossReferences":{"DailyMed":["pibrentasvir"],"drugbank":["DB13878"]},"count":4,"approvedIndications":["EFO_0004220"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2017 and is indicated for chronic hepatitis c virus infection and has 3 investigational indications."}
{"id":"CHEMBL3545231","canonicalSmiles":"c1ccc(-c2nnc(O[C@@H]3C4CC5C[C@H]3CN(C5)C4)s2)cc1","inchiKey":"QZDCYUCETTWCMO-CDFKWJNJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ABT-126","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Abt-126"],"count":2,"linkedTargets":{"rows":["ENSG00000175344"],"count":1},"linkedDiseases":{"rows":["EFO_0000249","EFO_0000692"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3545345","drugType":"Small molecule","blackBoxWarning":false,"name":"UR-63325","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Seliforant","UR-63325","Ur-63325"],"count":1,"linkedTargets":{"rows":["ENSG00000134489"],"count":1},"linkedDiseases":{"rows":["EFO_0003956"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545411","drugType":"Small molecule","blackBoxWarning":false,"name":"MF101","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mf101"],"count":2,"linkedTargets":{"rows":["ENSG00000140009"],"count":1},"linkedDiseases":{"rows":["HP_0031217","EFO_0003922"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3545419","drugType":"Antibody","blackBoxWarning":false,"name":"TELISOTUZUMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ABT-700","Abt-700","Telisotuzumab"],"count":1,"linkedTargets":{"rows":["ENSG00000105976"],"count":1},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3623004","canonicalSmiles":"C[C@@H]1Cc2c([nH]c3ccccc23)[C@@H](c2c(F)cc(/C=C/C(=O)O)cc2F)N1CC(C)(C)F","inchiKey":"DFBDRVGWBHBJNR-BBNFHIFMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZD-9496","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD9496","Azd 9496","Azd-9496","Azd9496"],"crossReferences":{"drugbank":["DB15138"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL363559","canonicalSmiles":"Cc1cn([C@H]2C[C@H](O)[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O2)c(=O)[nH]c1=O","inchiKey":"NHVNXKFIZYSCEB-XLPZGREQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEOXYTHYMIDINE_TRIPHOSPHATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["dTTP"],"crossReferences":{"Wikipedia":["Thymidine_triphosphate"],"drugbank":["DB02452"],"chEBI":["18077"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL36715","canonicalSmiles":"NC(=O)CN1CCCC1=O","inchiKey":"GMZVRMREEHBGGF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIRACETAM","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Gabacet","Nootrop","Nootrop 1200","Nootrop 400","Nootrop 800","Nootropil"],"synonyms":["CL-871","Piracetam"],"crossReferences":{"PubChem":["11111637","11111638","11532905","144203780","144212307","170465901","26747624","26747625","50106825","50106826","85231187","90341798"],"Wikipedia":["Piracetam"],"drugbank":["DB09210"]},"count":8,"approvedIndications":["EFO_0003888"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for attention deficit hyperactivity disorder and has 7 investigational indications."}
{"id":"CHEMBL3707349","canonicalSmiles":"CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\\C(=O)Nc3ccc(-c4csc(-c5ccccc5)n4)cc32)c1C","inchiKey":"QDWKGEFGLQMDAM-ULJHMMPZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMCASERTIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Amcasertib","BBI-503","BBI503"],"crossReferences":{"drugbank":["DB14866"]},"count":7,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL374107","canonicalSmiles":"Nc1nc(O)c2[nH]nnc2n1","inchiKey":"LPXQRXLUHJKZIE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"8-AZAGUANINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["8-Azaguanine"],"crossReferences":{"PubChem":["11112293","124899167","47193666","538242"],"Wikipedia":["8-Azaguanine"],"drugbank":["DB01667"],"chEBI":["63486"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3764913","canonicalSmiles":"C[C@H]1COc2c(C3(N)CC3)c(F)cc3c(=O)c(C(=O)[O-])cn1c23.[K+]","inchiKey":"LTIOYHPVKHXQLN-FJXQXJEOSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3764913","maximumClinicalTrialPhase":0,"parentId":"CHEMBL240163","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3785197","canonicalSmiles":"CCOC(=O)N1c2ccc(C(F)(F)F)cc2[C@@H](N(Cc2cc(C(F)(F)F)cc(C(F)(F)F)c2)c2ncc(OCCCC(=O)O)cn2)C[C@H]1CC","inchiKey":"NRWORBQAOQVYBJ-GJZUVCINSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OBICETRAPIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AMG-899","DEZ-001","Obicetrapib","TA-8995","Ta-8995"],"crossReferences":{"drugbank":["DB14890"]},"count":1,"linkedTargets":{"rows":["ENSG00000087237"],"count":1},"linkedDiseases":{"rows":["Orphanet_309005"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL398110","canonicalSmiles":"CCCn1cnc(C[C@H](CCCN)C(=O)O)c1","inchiKey":"OTDGPKRCQXSTPV-JTQLQIEISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"UK-396,082","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["UK 396082","UK-396082","Uk-396,082"],"crossReferences":{"drugbank":["DB12099"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL398428","canonicalSmiles":"CC(C)Oc1cccc(NC(=O)c2cc(Cl)c(OCCN)c(Cl)c2)c1","inchiKey":"AYKUIRSGEMLIFT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL398428","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08072"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3989650","canonicalSmiles":"CC1(C)[C@H](C(=O)O)N2C(=O)C[C@H]2S1(=O)=O.CC1(C)[C@H](C(=O)O)N2C(=O)C[C@H]2S1(=O)=O.c1ccc(CNCCNCc2ccccc2)cc1","inchiKey":"YSEPFTSCLHUBNH-HFKSPEPWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULBACTAM BENZATHINE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL403","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CP-45,899-99","Sulbactam benzathine"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3989738","canonicalSmiles":"CC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@H](C(=O)N[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H](CCN)NC1=O)[C@@H](C)O.CC[C@H](C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@H](C(=O)N[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H](CCN)NC1=O)[C@@H](C)O","inchiKey":"ZBJNZFQKYZCUJU-PAHFEQBRSA-N","drugType":"Protein","blackBoxWarning":true,"name":"POLYMYXIN B","yearOfFirstApproval":1957,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Polymyxin b"],"crossReferences":{"DailyMed":["polymyxin%20b%20sulfate"]},"childChemblIds":["CHEMBL3989714"],"count":5,"approvedIndications":["EFO_0000771","EFO_1001888"],"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1957 and is indicated for eye infection and bacterial disease and has 3 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3989862","canonicalSmiles":"C=C1/C(=C\\C=C2/CCC[C@]3(C)C([C@H](C)OCC(=O)NCC(F)(F)C(F)(F)F)=CC[C@@H]23)C[C@@H](O)C[C@@H]1O","inchiKey":"SVCSMAZYWOQCBW-NVJMFHFGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PEFCALCITOL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["M-5181","M-518101","M5181","M518101","Pefcalcitol"],"crossReferences":{"drugbank":["DB11786"]},"count":1,"linkedTargets":{"rows":["ENSG00000111424"],"count":1},"linkedDiseases":{"rows":["EFO_0000676"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL3990038","drugType":"Antibody","blackBoxWarning":false,"name":"FLOTETUZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Flotetuzumab","MGD-006","MGD006","RES-234","RES234","S-80880","S80880"],"count":1,"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL407632","canonicalSmiles":"CCOc1cc(OC)ccc1C1=N[C@@H](c2ccc(Br)cc2)[C@@H](c2ccc(Br)cc2)N1C(=O)N1CCN(CCO)CC1","inchiKey":"PVRYEWOXWGDQHA-URLMMPGGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NUTLIN-2","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Nutlin-2"],"crossReferences":{"drugbank":["DB02872"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4101807","canonicalSmiles":"CC(C)n1nccc1-c1ncccc1COc1cccc(O)c1C=O","inchiKey":"FWCVZAQENIZVMY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VOXELOTOR","yearOfFirstApproval":2019,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Oxbryta"],"synonyms":["GBT-440","GBT440","GTX-011","Gbt440","Voxelotor"],"crossReferences":{"DailyMed":["voxelotor"],"drugbank":["DB14975"]},"count":4,"approvedIndications":["Orphanet_232"],"linkedTargets":{"rows":["ENSG00000244734","ENSG00000188536","ENSG00000206172"],"count":3},"linkedDiseases":{"rows":["EFO_0003086","Orphanet_232","EFO_0000768","EFO_0001421"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2019 and is indicated for sickle cell anemia and has 3 investigational indications."}
{"id":"CHEMBL411879","canonicalSmiles":"C/C1=C/C(=O)O[C@@H]2C[C@@H](CC[C@H](C)/C=C\\CC1)O[C@@](O)([C@@H]1CSC(=O)N1)C2","inchiKey":"NSHPHXHGRHSMIK-JRIKCGFMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LATRUNCULIN B","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-339663"],"crossReferences":{"drugbank":["DB08080"],"chEBI":["49703"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL420671","canonicalSmiles":"CCOC(=O)N1CCC(Nc2cc(C)ccn2)CC1","inchiKey":"LNRMJBWADUSJTA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL420671","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07388"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297181","canonicalSmiles":"CO[C@@H](C)Cn1c(=O)n(C)c2cnc3ccc(-c4cncc(C(C)(C)O)c4)cc3c21","inchiKey":"ACCFLVVUVBJNGT-AWEZNQCLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SAMOTOLISIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LY 3023414","LY-3023414","LY3023414","Ly-3023414","Samotolisib"],"crossReferences":{"drugbank":["DB12167"]},"count":11,"linkedTargets":{"rows":["ENSG00000145675","ENSG00000171608","ENSG00000105647","ENSG00000141506","ENSG00000051382","ENSG00000121879","ENSG00000105851","ENSG00000117461","ENSG00000198793"],"count":9},"linkedDiseases":{"rows":["EFO_0000616","EFO_0003869","EFO_0000588","EFO_0002517","MONDO_0011962","MONDO_0007254","EFO_0004142","EFO_0005952","MONDO_0024880","EFO_0003060","MONDO_0008315","EFO_0009708"],"count":12},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 11 investigational indications."}
{"id":"CHEMBL4297257","canonicalSmiles":"CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCNC(=O)COCCOCCNC(=O)CCN1C(=O)C=CC1=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(C)=O)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O","inchiKey":"DJIGFNCGXOAXOW-WTPNCWHFSA-N","drugType":"Protein","blackBoxWarning":false,"name":"ALBUVIRTIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Albuvirtide","FB-006M"],"count":2,"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297279","canonicalSmiles":"NC(=O)CC[C@@H](C(=O)O)N(CCNC(=S)Nc1ccc2c(c1)C(=O)OC21c2ccc(O)cc2Oc2cc(O)ccc21)C(=O)c1ccc(NCc2cnc3nc(N)[nH]c(=O)c3n2)cc1","inchiKey":"ZMTAPBHUSYTHBY-PMERELPUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EC-17","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ec 17","Ec-17","Ec17 (folate-fitc)"],"crossReferences":{"drugbank":["DB12559"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297355","canonicalSmiles":"C[C@@H](C1CC1)N1Cc2cc(-c3cc(C(=O)N(C)C)no3)cc(Cl)c2C1=O","inchiKey":"MCPBSUCAISQZQK-JTQLQIEISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZD-8418","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD8418","Azd 8418","Azd-8418","Azd8418"],"crossReferences":{"drugbank":["DB13102"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297572","drugType":"Unknown","blackBoxWarning":false,"name":"ABBV-3373","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ABBV-3373","Abbv-3373"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297580","drugType":"Antibody","blackBoxWarning":false,"name":"ETOKIMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ANB-020","ANB020","Anb020","Etokimab"],"count":4,"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL4297591","canonicalSmiles":"Nc1c(-c2cc(Cc3ccc(COc4ccccn4)cc3)no2)ccc[n+]1COP(=O)([O-])O","inchiKey":"JQONJQKKVAHONF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FOSMANOGEPIX","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["APX001","Apx001","E1211","Fosmanogepix"],"crossReferences":{"drugbank":["DB15183"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297667","canonicalSmiles":"NC(=O)NCCC[C@H](N)C(=O)O.O=C(O)CC(O)C(=O)O","inchiKey":"DROVUXYZTXCEBX-WCCKRBBISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CITRULLINE MALATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL444814","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Citrulline malate","Citrulline malate (salt)","L-citrulline malate"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297703","drugType":"Unknown","blackBoxWarning":false,"name":"BMS-962476","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bms-962476"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297881","drugType":"Unknown","blackBoxWarning":false,"name":"AMG-427","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AMG 427","AMG-427","Amg 427","Amg-427"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297907","drugType":"Antibody","blackBoxWarning":false,"name":"TETULOMAB TETRAXETAN LU-177","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Betalutin","Tetulomab tetraxetan lu-177"],"count":3,"description":"Antibody drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4298136","drugType":"Unknown","blackBoxWarning":false,"name":"AR-177","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AR177","Ar-177","T-30177","Zintevir"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4298197","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"VUPANORSEN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AKCEA-ANGPTL3-LRx","ISIS 703802","ISIS-703802","Vupanorsen"],"count":2,"description":"Oligonucleotide drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4303667","canonicalSmiles":"CN(C)C(=O)Oc1ccc[n+](C)c1.[I-]","inchiKey":"UQAPNCDQRWJKSA-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL4303667","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1115","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL432481","canonicalSmiles":"C[C@]1(C(=O)O)CSC(c2ccc(O)cc2O)=N1","inchiKey":"OEUUFNIKLCFNLN-LLVKDONJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEFERITRIN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Deferitrin","GT-56-252","GT56-252"],"childChemblIds":["CHEMBL523672"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL439044","canonicalSmiles":"CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O","inchiKey":"GTYWGUNQAMYZPF-QPLNMOKZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL439044","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB13798"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL445813","canonicalSmiles":"O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl","inchiKey":"OVPNQJVDAFNBDN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AT-7519","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AT 7519","AT-7519","AT7519","At-7519"],"crossReferences":{"PubChem":["137275934","137275935"],"drugbank":["DB08142"]},"childChemblIds":["CHEMBL497478"],"count":5,"linkedTargets":{"rows":["ENSG00000250506","ENSG00000156345","ENSG00000164885","ENSG00000134058","ENSG00000123374","ENSG00000135446","ENSG00000155111","ENSG00000059758","ENSG00000105810","ENSG00000136807","ENSG00000167258","ENSG00000138395","ENSG00000058091","ENSG00000248333","ENSG00000132964","ENSG00000117266","ENSG00000065883","ENSG00000102225","ENSG00000170312","ENSG00000185324"],"count":20},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000095","EFO_0000574","EFO_0001378","EFO_1001469"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL448","canonicalSmiles":"CCCC(C)C1(CC)C(=O)NC(=O)NC1=O","inchiKey":"WEXRUCMBJFQVBZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PENTOBARBITAL","yearOfFirstApproval":1973,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["Norway"],"classes":["Misuse"],"year":1980},"tradeNames":["Nembutal"],"synonyms":["Mebubarbital","Mebumal","NSC-28708","Pentobarbital","Pentobarbital calcium","Pentobarbital cii"],"crossReferences":{"DailyMed":["pentobarbital%20sodium"],"PubChem":["144205108","26750091"],"Wikipedia":["Pentobarbital"],"drugbank":["DB00312"],"chEBI":["7983"]},"childChemblIds":["CHEMBL971"],"count":4,"linkedTargets":{"rows":["ENSG00000145864","ENSG00000166206","ENSG00000163288"],"count":3},"linkedDiseases":{"rows":["EFO_0008526","EFO_0003777","EFO_0003890","MONDO_0043510"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1973 and has 4 investigational indications. It was withdrawn in Norway  in 1980 due to Misuse."}
{"id":"CHEMBL453","canonicalSmiles":"Cc1noc(NS(=O)(=O)c2ccc(N)cc2)c1C","inchiKey":"NHUHCSRWZMLRLA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULFISOXAZOLE","yearOfFirstApproval":1971,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Entusil","Gantrisin","Neazolin","Sosol","Soxazole","Sulfafurazole","Sulfalar","Sulfisoxazole","Sulphafurazole","Sulsoxin"],"synonyms":["Eryzole","NSC-13120","NSC-683536","Pediazole","Sulfafurazole","Sulfisoxazole","Sulphafurazole"],"crossReferences":{"PubChem":["11112277","11113344","124882166","144203960","144206511","144209463","144213168","170464636","17389726","26751527","859862"],"Wikipedia":["Sulfafurazole"],"drugbank":["DB00263"],"chEBI":["102484"]},"childChemblIds":["CHEMBL1200321"],"count":3,"approvedIndications":["EFO_0000771","EFO_1001888"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1971 and is indicated for bacterial disease and eye infection and has 1 investigational indication."}
{"id":"CHEMBL455","canonicalSmiles":"CC(=O)NS(=O)(=O)c1ccc(N)cc1","inchiKey":"SKIVFJLNDNKQPD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULFACETAMIDE","yearOfFirstApproval":1945,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Klaron"],"synonyms":["Bleph-10","Bleph-30","Cetamide","FML-S","Klaron","NSC-63871","Ocusulf-10","Ocusulf-30","SULF-10","SULF-15","Sulfacel-15","Sulfacetamide","Sulfacetamide (triple sulfa)","Sulfair-15","Sulphacetamide","Sulster","Sulten-10"],"crossReferences":{"DailyMed":["sulfacetamide%20sodium"],"PubChem":["144204397","144209197","144213417","170464944","17388721","56422206","855639"],"Wikipedia":["Sulfacetamide"],"drugbank":["DB00634"],"chEBI":["63845"]},"childChemblIds":["CHEMBL1200416","CHEMBL1723241"],"count":3,"approvedIndications":["EFO_1001888","EFO_0003894"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1945 and is indicated for eye infection and acne and has 1 investigational indication."}
{"id":"CHEMBL455706","canonicalSmiles":"C[C@H]1CC2=CC(=O)CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@]3(C)O)[C@H]12","inchiKey":"IVFYLRMMHVYGJH-PVPPCFLZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CALUSTERONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Calusterone","U-22,550"],"crossReferences":{"drugbank":["DB01564"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4594275","canonicalSmiles":"N#CCC1CCN(c2nc(Nc3ccc(N4CCC(O)CC4)cc3)c3c(=O)[nH]ncc3n2)CC1","inchiKey":"NLFLXLJXEIUQDL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GUSACITINIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ASN-002","ASN002","Asn-002","Asn002","EN-3351","EN3351","Gusacitinib"],"childChemblIds":["CHEMBL4594276"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4594403","canonicalSmiles":"CC1=CN2CCS(=O)(=O)N=C2C(c2ccc(OC3CCCCC3)cc2)=N1","inchiKey":"PXJBHEHFVQVDDS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TAK-653","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tak-653"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4594453","canonicalSmiles":"CC(C)OC(=O)OCOP(=O)(CO[C@H](C)Cn1cnc2c(N)ncnc21)OCOC(=O)OC(C)C.N[C@@H](CC(=O)O)C(=O)O","inchiKey":"CCIDLBRRXVNEDK-KJTVYDLOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TENOFOVIR DISOPROXIL ASPARTATE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL1538","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CKD-390","Ckd-390","Tenofovir disoproxil aspartate"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4594584","drugType":"Unknown","blackBoxWarning":false,"name":"ANTIHEMOPHILIC FACTOR, PEGYLATED (MW 20000) HUMAN SEQUENCE RECOMBINANT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Antihemophilic factor, pegylated (mw 20000) human sequence recombinant","Pegylated recombinant factor viii","Rurioctocog alfa pegol"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4594604","drugType":"Antibody","blackBoxWarning":false,"name":"RIPERTAMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ripertamab","SCT-400","SCT400","Sct400"],"count":1,"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL46257","canonicalSmiles":"NCCCCN","inchiKey":"KIDHWZJUCRJVML-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PUTRESCINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-60545","Putrescine"],"crossReferences":{"PubChem":["11111663","90341517"],"Wikipedia":["Putrescine"],"drugbank":["DB01917"],"chEBI":["17148"]},"childChemblIds":["CHEMBL1528028","CHEMBL1255652","CHEMBL3229239"],"description":"Small molecule drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL462712","canonicalSmiles":"CN1CCN(c2cnc3cc(C(F)(F)F)cc(-c4cccc(O)c4)c3n2)CC1","inchiKey":"QNCYYRHIUFGGJX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL462712","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07969"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL478381","canonicalSmiles":"N[C@@H](CCC(=O)Nc1ccc(OCc2ccccc2)cc1)C(=O)O","inchiKey":"BYSBXIPCDJNEBG-INIZCTEOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL478381","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07102"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL478524","canonicalSmiles":"Cc1ccc(-n2cc(CNCC3CCCCC3)c3ccccc32)cc1","inchiKey":"MMIJMYOYKAKQPN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL478524","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06833"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL479880","canonicalSmiles":"CCCCNS(=O)(=O)c1ccccc1","inchiKey":"IPRJXAGUEGOFGG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"N-Butylbenzenesulfonamide","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["N-Butylbenzenesulfonamide"],"crossReferences":{"PubChem":["144208890","144213501"],"drugbank":["DB02055"],"chEBI":["44237"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL48109","canonicalSmiles":"Cc1nc(C)c(-c2ccnc(Nc3ccc(C(F)(F)F)cc3)n2)s1","inchiKey":"MEZFDQUDLQCVNX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL48109","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02915"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL485259","canonicalSmiles":"CC12CCC(CC1)C(C)(C)O2","inchiKey":"WEEGYLXZBRQIMU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EUCALYPTOL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cineole","Eucalyptol","FEMA NO. 2465","NSC-6171"],"crossReferences":{"PubChem":["144204712","144209288","144213219","170465483","17389880","47193678","72164"],"Wikipedia":["Eucalyptol"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL485659","canonicalSmiles":"C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)COC(=O)CCC(=O)O","inchiKey":"APGDTXUMTIZLCJ-CGVGKPPMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PREDNISOLONE HEMISUCCINATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Prednisolone hemisuccinate","Prednisolone succinate"],"crossReferences":{"PubChem":["144206954"],"drugbank":["DB14633"]},"childChemblIds":["CHEMBL1412530"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL48608","canonicalSmiles":"Cc1cc(Br)c(O)c(-c2cc3cc(C(=N)N)ccc3[nH]2)c1","inchiKey":"BVTBOJXEAPSOEB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL48608","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04215"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL487431","canonicalSmiles":"Cc1ccc(C(=O)NCCC2CCCC2)cc1C(=O)Nc1ccc(N)nc1","inchiKey":"CLEGTVIMOPPIBR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL487431","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07537"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL515387","canonicalSmiles":"O=C([C@@H]1C[C@H](N2CCN(c3ncccn3)CC2)CN1)N1CCC(F)(F)C1","inchiKey":"QWEWGXUTRTXFRF-KBPBESRZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GOSOGLIPTIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gosogliptin","PF-00734200","PF-734,200","PF-734200"],"crossReferences":{"drugbank":["DB08382"]},"childChemblIds":["CHEMBL3526419"],"count":2,"linkedTargets":{"rows":["ENSG00000197635"],"count":1},"linkedDiseases":{"rows":["EFO_0003884","EFO_0001360"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL553025","canonicalSmiles":"CCC1=C[C@@H]2CN(C1)Cc1c([nH]c3ccccc13)[C@@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2","inchiKey":"GBABOYUKABKIAF-IELIFDKJSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"VINORELBINE","yearOfFirstApproval":1994,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Vinorelbine","Vinorelbine Base"],"crossReferences":{"DailyMed":["vinorelbine%20tartrate"],"PubChem":["124893200","29217724","50111727"],"drugbank":["DB00361"],"chEBI":["480999"]},"childChemblIds":["CHEMBL538943"],"count":33,"approvedIndications":["EFO_0000616","EFO_0000311"],"linkedTargets":{"rows":["ENSG00000261456","ENSG00000188229","ENSG00000104833","ENSG00000137267","ENSG00000258947","ENSG00000101162","ENSG00000196230","ENSG00000137285","ENSG00000176014"],"count":9},"linkedDiseases":{"rows":["MONDO_0009348","EFO_1000172","EFO_0003869","EFO_0004708","MONDO_0015686","EFO_0000571","MONDO_0021117","MONDO_0007254","EFO_0001071","EFO_0005952","MONDO_0021063","MONDO_0001187","EFO_0000565","MONDO_0002158","EFO_0000588","MONDO_0002974","EFO_0000770","MONDO_0008903","EFO_0000389","EFO_0002918","EFO_0000183","EFO_0002617","EFO_0001416","EFO_0000616","MONDO_0001402","EFO_0005922","EFO_0000437","EFO_0000248","MONDO_0008170","EFO_0000403","EFO_0000313","EFO_0003060","MONDO_0008315","EFO_0000621","EFO_0000311","EFO_0000211","EFO_1000026","EFO_0003032","EFO_0006861","EFO_0005537","MONDO_0011962","EFO_0004284","EFO_0000702","EFO_0000574","MONDO_0002367","MONDO_0002863","EFO_0001378","EFO_0000233","MONDO_0017386","EFO_1000895","EFO_0003050","EFO_0000691","MONDO_0021637","MONDO_0024880"],"count":54},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1994 and is indicated for neoplasm and cancer and has 31 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL555201","canonicalSmiles":"COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC.Cl","inchiKey":"HNJNNCPPISFBGR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL555201","maximumClinicalTrialPhase":0,"parentId":"CHEMBL405130","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL563251","canonicalSmiles":"CN1C[C@H]2[C@@H](C1)[C@@H]2CN(Cc1ccc(F)c(Cl)c1)C(=O)c1cn(C)cn1","inchiKey":"KYLOBHXXQOZRKK-FICVDOATSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PF-03463275","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pf-03463275","Pf-3463275"],"crossReferences":{"drugbank":["DB11993"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL565","canonicalSmiles":"CCOC(=O)C(C)(C)Oc1ccc(Cl)cc1","inchiKey":"KNHUKKLJHYUCFP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLOFIBRATE","yearOfFirstApproval":1967,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Atromid","Atromid-s","Clofibrate"],"synonyms":["AY-61123","Chlorfenisate","Clofibrate","ICI 28257","ICI-28257","NSC-79389"],"crossReferences":{"PubChem":["11110971","119396","124879709","144203667","144209612","170465329","50106069","57260455","85230976","90341380"],"TG-GATEs":["6"],"Wikipedia":["Clofibrate"],"drugbank":["DB00636"],"chEBI":["3750"]},"count":3,"approvedIndications":["EFO_0000319"],"linkedTargets":{"rows":["ENSG00000186951"],"count":1},"linkedDiseases":{"rows":["EFO_1001375","EFO_0000612","EFO_0000319"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1967 and is indicated for cardiovascular disease and has 2 investigational indications."}
{"id":"CHEMBL568","canonicalSmiles":"O=C1Nc2ccc(Cl)cc2C(c2ccccc2)=NC1O","inchiKey":"ADIMAYPTOBDMTL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"OXAZEPAM","yearOfFirstApproval":1965,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Lederpam","Oxazepam","Serax","Serenid fte","Zaxopam"],"synonyms":["J3.308A","NSC-169448","Oxazepam","Oxazepam civ","Oxozepam","Temazepam impurity, oxazepam-","WY-3498"],"crossReferences":{"DailyMed":["oxazepam"],"PubChem":["144205125","144206372","144207898","144213809","29215230"],"Wikipedia":["Oxazepam"],"drugbank":["DB00842"],"chEBI":["7823"]},"childChemblIds":["CHEMBL3251468"],"count":6,"approvedIndications":["EFO_0005230"],"linkedTargets":{"rows":["ENSG00000022355","ENSG00000182256","ENSG00000011677","ENSG00000163285","ENSG00000113327","ENSG00000151834","ENSG00000186297"],"count":7},"linkedDiseases":{"rows":["EFO_0004777","MONDO_0002050","HP_0000726","EFO_0000764","EFO_0003768","EFO_0010445","EFO_0005230","EFO_0000692","EFO_0003829"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1965 and is indicated for anxiety and has 5 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL577","canonicalSmiles":"C[C@H](N[C@@H](CCc1ccccc1)C(=O)O)C(=O)N1CCC[C@H]1C(=O)O","inchiKey":"LZFZMUMEGBBDTC-QEJZJMRPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ENALAPRILAT","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Vasotec"],"synonyms":["Enalaprilat","MK-421","MK-422"],"crossReferences":{"DailyMed":["enalaprilat"],"Wikipedia":["Enalaprilat"],"drugbank":["DB09477"],"chEBI":["4786"]},"childChemblIds":["CHEMBL3989406"],"linkedTargets":{"rows":["ENSG00000159640"],"count":1},"linkedDiseases":{"rows":["EFO_0001360","EFO_0000407","EFO_0000537"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL592435","canonicalSmiles":"OC1CCC(Nc2nc(-c3ccccc3)nc3[nH]ccc23)CC1","inchiKey":"RBZNJGHIKXAKQE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DERENOFYLLINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Derenofylline","SLV-320","SLV320","Slv320"],"count":1,"linkedTargets":{"rows":["ENSG00000163485"],"count":1},"linkedDiseases":{"rows":["EFO_0000373"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL593442","canonicalSmiles":"Cc1ccnc2c1ccc1c(C)ccnc12","inchiKey":"JIVLDFFWTQYGSR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL593442","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02586"]},"childChemblIds":["CHEMBL1338667"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL594972","canonicalSmiles":"OC[C@H]1O[C@@]2(CC(c3ccccc3)=NO2)[C@H](O)[C@@H](O)[C@@H]1O","inchiKey":"YLTDNVVQKRHCJP-RKQHYHRCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL594972","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08151"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL608806","canonicalSmiles":"CCOC(=O)[C@@H]1C2CCC(C[C@@H]1OC(=O)c1ccccc1)N2C","inchiKey":"NMPOSNRHZIWLLL-SSHXOBKSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"COCAETHYLENE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cocaethylene","ETHYLCOCAINE","J21.586D"],"crossReferences":{"Wikipedia":["Cocaethylene"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL61006","canonicalSmiles":"CC(N)C(O)c1ccccc1","inchiKey":"DLNKOYKMWOXYQA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENYLPROPANOLAMINE","yearOfFirstApproval":1958,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"],"classes":["Neurotoxicity"],"year":2002},"tradeNames":[],"synonyms":["Phenylpropanolamine"],"childChemblIds":["CHEMBL1200695","CHEMBL2146104","CHEMBL1201535"],"count":1,"approvedIndications":["HP_0001742"],"linkedTargets":{"rows":["ENSG00000103546","ENSG00000120907"],"count":2},"linkedDiseases":{"rows":["EFO_0000270","HP_0001742"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1958 and is indicated for nasal obstruction. It was withdrawn in United States  in 2002 due to Neurotoxicity."}
{"id":"CHEMBL62136","canonicalSmiles":"O=S(=O)(c1ccccc1)N(CC(F)(F)F)c1ccc(C(O)(C(F)(F)F)C(F)(F)F)cc1","inchiKey":"SGIWFELWJPNFDH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"T091317","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["T0901317"],"crossReferences":{"PubChem":["124892235","26754513","29215533","85257301","99495594"],"drugbank":["DB07080"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL62897","canonicalSmiles":"Cc1cc(I)c(O)c(C(=O)Nc2ccc(C(=N)N)c(Cl)c2)c1","inchiKey":"QKGFTDAISIBIBV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL62897","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06857"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL67133","canonicalSmiles":"C=CCN(C)CCCCCCOc1ccc2c(-c3ccc(Br)cc3)nsc2c1","inchiKey":"UCIDPJLYUKNYFZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL67133","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02544"]},"childChemblIds":["CHEMBL112210"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL74355","canonicalSmiles":"COc1cccc([C@H](O)C2CCN(CCc3ccc(F)cc3)CC2)c1OC","inchiKey":"HXTGXYRHXAGCFP-OAQYLSRUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VOLINANSERIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["M-100907","M100907","MDL-100.907","MDL-100907","MDL100.907","Mdl-100907","Volinanserin"],"crossReferences":{"PubChem":["144210564"],"Wikipedia":["Volinanserin"]},"count":2,"linkedTargets":{"rows":["ENSG00000102468"],"count":1},"linkedDiseases":{"rows":["MONDO_0002050","EFO_0004698"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL744","canonicalSmiles":"Nc1nc2ccc(OC(F)(F)F)cc2s1","inchiKey":"FTALBRSUTCGOEG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RILUZOLE","yearOfFirstApproval":1995,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Exservan","Rilutek","Riluzole","Teglutik","Tiglutik kit"],"synonyms":["BHV-0223","RP 54274","RP-54274","Riluzole"],"crossReferences":{"DailyMed":["riluzole"],"PubChem":["104171227","11111723","11113346","124881305","144203803","170464928","26751529","50104104","85231207","855844","90341557"],"Wikipedia":["Riluzole"],"drugbank":["DB00740"],"chEBI":["8863"]},"childChemblIds":["CHEMBL1531817"],"count":22,"linkedTargets":{"rows":["ENSG00000185313","ENSG00000153253","ENSG00000183873","ENSG00000136546","ENSG00000144285","ENSG00000169432","ENSG00000168356","ENSG00000136531","ENSG00000007314","ENSG00000196876"],"count":10},"linkedDiseases":{"rows":["EFO_0008525","EFO_0003756","Orphanet_98756","MONDO_0002009","EFO_0000249","MONDO_0007254","EFO_1001919","EFO_0001358","MONDO_0000437","Orphanet_908","EFO_1001050","EFO_0003885","EFO_0001072","Orphanet_399","EFO_0000289","MONDO_0002050","Orphanet_683","Orphanet_94147","EFO_0004895","EFO_0000389","EFO_0003100","EFO_0000253","HP_0002196","EFO_0004242","MONDO_0024880","EFO_0008522"],"count":26},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1995 and has 22 investigational indications."}
{"id":"CHEMBL817","canonicalSmiles":"Cc1ccc(S(=O)(=O)NC(=O)NN2CCCCCC2)cc1","inchiKey":"OUDSBRTVNLOZBN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TOLAZAMIDE","yearOfFirstApproval":1966,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tolazamide","Tolinase"],"synonyms":["Tolazamide","U-17835"],"crossReferences":{"PubChem":["11111870","124881598","144203832","144208705","144210734","170465136","26747047","26751566","50104182","56422126","85231252","855941"],"Wikipedia":["Tolazamide"],"drugbank":["DB00839"],"chEBI":["9613"]},"count":2,"approvedIndications":["EFO_0001360","EFO_0000400"],"linkedTargets":{"rows":["ENSG00000187486","ENSG00000006071"],"count":2},"linkedDiseases":{"rows":["EFO_0001360","EFO_0000400"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1966 and is indicated for diabetes mellitus and type ii diabetes mellitus."}
{"id":"CHEMBL83547","canonicalSmiles":"Cc1ccc(Sc2cccc3nc(N)nc(N)c23)cc1","inchiKey":"UOJFGEAPSYQDIP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL83547","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04306"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL858","canonicalSmiles":"O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CC(=O)O","inchiKey":"KCXVZYZYPLLWCC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EDETIC ACID","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Versene acid"],"synonyms":["Edetate","Edetic Acid","Edetic acid","Edta"],"crossReferences":{"PubChem":["144209934","26754509","29215444"],"Wikipedia":["Ethylenediaminetetraacetic_acid"],"drugbank":["DB00974"],"chEBI":["42191"]},"description":"Small molecule drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL86954","canonicalSmiles":"NCC(N)=O","inchiKey":"BEBCJVAWIBVWNZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMINOMETHYLAMIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-Amino-Acetamide"],"crossReferences":{"drugbank":["DB03636"],"chEBI":["42843"]},"childChemblIds":["CHEMBL1222057"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL8943","canonicalSmiles":"O=C(C[C@@H](Cc1cccc(O)c1)C(=O)N[C@H]1c2ccccc2C[C@H]1O)NO","inchiKey":"VXDKQRWTOJFQKH-BJZITVGISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL8943","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06837"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
